Franck E. Nicolini

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP)

Franck E. Nicolini, Sélim Corm, Q.H. Le et al. · Leukemia · 2006 · 203 citations

Hematological Malignancy, Medicine, Hematology +9

Granulocyte–macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)

Xavier Thomas, Pierre Fenaux, Hervé Dombret et al. · Leukemia · 1999 · 76 citations

Hematological Malignancy, Ema91 Trial, Medicine +10

First-line imatinib mesylate in patients with newly diagnosed accelerated phase-chronic myeloid leukemia

Delphine Réa, Gabriel Étienne, Franck E. Nicolini et al. · Leukemia · 2012 · 44 citations

Hematological Malignancy, Medicine, Hematology +7

Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer

Pierre-Étienne Heudel, Sylvie Chabaud, David Pérol et al. · ESMO Open · 2021 · 30 citations · Full text

S881 PREGNANCY OUTCOME IN FEMALE PATIENTS WITH CHRONIC MYELOID LEUKEMIA WORLDWIDE: ANALYSIS OF 305 CASES OF THE EUROPEAN LEUKEMIA NET REGISTRY

Ekaterina Chelysheva, Anna Turkina, Delphine Réa et al. · HemaSphere · 2019 · 10 citations · Full text

Reproductive Health, Gynecology, High-risk Pregnancy +20